ELNs to Optimise Patent Protection
- Advantages of ELNs for patients.
- Uses of ELNs for IP matters.
- Ligitation risks of ELNs.
-
Retrievability of ELNs
![]() |
What Does The Future Hold For Electronic Lab Notebooks In 2012?
Download the free 2012 ELN Global Forecast eBook now to find out!
-
Engineering Cocrystal Solubility and Streamlining Cocrystal Selection -
Grinding as a Route to Single Chirality -
Effective Methods of Amorphous Particle Engineering and Downsizing the Amorphous Form -
Characterisation of Composite Materials Containing Amorphous/Nanocrystalline Phases -
Gaining FDA approval - Development and Validation of a Drug Product Solid State Method for a NDA -
Enhancing the Drug Development Strategy for Pharmaceutical Co-crystals -
Cultivating Co-Crystals: From Crystal Engineering to Crystal Growth and Back... -
Structure-Property Relationships in Multiple Component Crystalline Solids -
Developing Clinical Trials for Oncology - Denis Mir, Eisai Global Clinical Development -
SME Case Study: Improving Throughput of Compound Handling, Quality of Compounds and Flexibility of Service
You Should Check Out:
* = required.
Not a member yet? Sign up
Events of Interest
-
Patient Flow Optimisation Asia 2012
Prince Hotel & Residence, Kuala Lumpur, Malaysia
June 20- 21, 2012 -
ELNs Master Class
March 29, 2012
Register Now -
Next chapter in the ELN evolution: From Discipline Specific Electronic Lab Notebook to a Company Wide Solution
February 22, 2010
Register Now -
Distinguishing Between ELNs and LIMS
November 21, 2011
Register Now
You Might Also Like
-
How to Unify the Requirements of Chemistry and Biology with a Single ELN
Pharma IQ are joined today by Dr. Ian Berry, Principal Scientist, Applications Developer and eScience
Pharma IQ
-
Novo Nordisk's Søren Skovlund Speaks to Pharma IQ about Best Practice Approaches to Patient Education and Self-Management
Søren Skovlund is director of global patient research, advocacy and support in Novo Nordisk and... Read more
Soren Skovlund
-
How ELNs Can Help Maximise Biopharmaceutical Lab Efficiency
Discover first hand how Roche deployed an ELN within the biopharmaceutical area. This interview with Ralph
Pharma IQ
-
Sharpen up on Patient Self-Management Approaches
Soren Skovlund, Director of Patient Research, Advocacy and Support at NovoNordisk, joins Helen Winsor from
Helen Winsor







Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!